Kulkarni Sandeep Chidambar — SEC Form 4 filings
SEC reporting owner CIK 1945691. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-08-20 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 307,000 shares, $98,416 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 5,221 shares @ $13.79 ($71,998) in Tourmaline Bio, Inc., filed 2024-08-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tourmaline Bio, Inc. (TRML) | CEO, Director | 5 | 2 legs · 7,000 sh · $98,416 | — | 9 |
| Amanat Acquisition Corp. (AMAN) | Director and Chairman, Director, 10% owner | 2 | 1 leg · 300,000 sh | — | 1 |
| Zura Bio Ltd (ZURA) | Chief Executive Officer, Director | 4 | — | — | 4 |
Form 4 filings — Kulkarni Sandeep Chidambar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Amanat Acquisition Corp. (AMAN) | Other (J): 281,250 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Amanat Acquisition Corp. (AMAN) | Purchase (P): 300,000 | EDGAR |
| 2026-04-02 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 894,000 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 2,934,107 (derivative) @ $0 | EDGAR |
| 2025-10-28 | 4 | Tourmaline Bio, Inc. (TRML) | Code (U): 724,664 · Disposition to issuer (D): 30,387 · Code (U): 7,000 · Disposition to issuer (D): 503,478 (derivative) · Disposition to issuer (D): 254,207 (derivative) · Disposition to issuer (D): 226,000 (derivative) | EDGAR |
| 2025-10-24 | 4 | Tourmaline Bio, Inc. (TRML) | Option exercise (M): 25,316 @ $7.90 · Option exercise (M): 25,316 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Tourmaline Bio, Inc. (TRML) | Grant/award (A): 226,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Zura Bio Ltd (ZURA) | Grant/award (A): 117,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Tourmaline Bio, Inc. (TRML) | Purchase (P): 1,779 @ $14.85 | EDGAR |
| 2024-08-20 | 4 | Tourmaline Bio, Inc. (TRML) | Purchase (P): 5,221 @ $13.79 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1945691 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →